EXC vs GKOS · P/E 17, rev $24.26B vs rev $336.2M
Exelon Corporation (EXC) versus Glaukos Corp (GKOS) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Glaukos Corp (GKOS) is a medical devices company listed on NYSE.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported GKOS revenue for 2026-06-30 was $336.2M. Net income was -$38.2M. GKOS currently screens at market cap $7.63B.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. GKOS currently screens at market cap $7.63B.
Not investment advice. Open the EXC and GKOS stock pages for the full models.
Not investment advice.